Clinical Trial Update: Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population

View source ↗

Summary

A clinical trial update evaluating lay user usability of Abbott's Panbio HCV self-test in an EU population, focusing on ease of use and comprehension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Abbott Rapid Dx | Conditions: Hepatitis C | Status: NOT_YET_RECRUITING